NEPHROCARE HEALTH SERV L

Management reported that Nephrocare Health Services Limited (NephroPlus) began FY27 with a strong performance, achieving over 20% revenue growth year-on-year in Q1 FY27, with revenues reaching INR 282 crores. The company emphasized its focus on three core pillars: quality, accessibility, and affordability in dialysis care. NephroPlus expanded its network by adding 26 clinics, bringing the total to 550 across five countries. The international operations contributed approximately 45% of revenue. Management highlighted the importance of disciplined capital allocation and maintaining clinical quality, with initiatives like the NephroPlus International Dialysis Academy aimed at addressing workforce challenges. The adjusted EBITDA grew by 30.7% to INR 65 crores, with margins improving to 23.1%. Management reiterated its growth strategy, focusing on increasing guest volumes, expanding clinic footprints, and entering new markets.

Management highlighted strong revenue growth and strategic expansion initiatives.